Click here to sign up for the Nova Scotia Health Innovation Hub newsletter and never miss an update
News Article
Patients can better prepare for and recover from surgery, thanks to Nova Scotia Health partnership with SeamlessMD
May 16, 2023
2
Min Read
The digital care journey platform enhances the patient experience and reduces the surgical backlog May 18, 2023 (Halifax, NS) – Nova Scotia Health announced today the launch of the SeamlessMD Digital Care Journey app for remote monitoring of gynecology oncology...
News Article
Research, Innovation and Discovery: the role of the Nova Scotia Health Innovation Hub
May 15, 2024
3
Min Read
By: Allison Currie In the complex and ever evolving healthcare landscape, innovation drives the kind of solutions that improve the system for both patients and healthcare providers. The Nova Scotia Health Innovation Hub has emerged as a leader of creativity...
News Article
Advancing health care simulation in Nova Scotia
September 15, 2022
4
Min Read
Just as flight simulators have been the standard learning and testing model for the airline industry for many years, the use of simulation can be the answer to developing health professionals’ knowledge, skills, and attitudes, while maintaining patient safety. Providing...
News Article
New initiative ensures more Nova Scotians are connected to a primary care provider
October 12, 2022
2
Min Read
It’s clear that there is a great need to enhance access to care, as we are facing many challenges related to the pandemic, crisis level staffing shortages, along with recruitment and retention issues especially in rural communities across the province...
page
Department of Health and Wellness' Priority Research Fund 2026
innovationhub.nshealth.ca/grants-and-funding-opportunities/department-health-and-wellness-priority-research-fund-2026
Anticipated Competition Timeline: Deadline Date Application Launch March 16, 2026 Full Application Deadline May 1, 2026 Dissemination of Competition Results Summer 2026 Program Overview The Department of Health and Wellness (DHW) 2026 Priority Fund will support targeted projects dedicated to work that align with the province’s health research priorities. This...
News Article
Making Waves: Honouring Outstanding Researcher, Dr. Ratika Parkash
June 3, 2022
2
Min Read
Nova Scotia Health prides itself on achieving excellence in health, healing and learning. Dr. Ratika Parkash’s research studies are doing just that – by extending new knowledge and care about cardiac health in Nova Scotia and Canada, as well as...
News Article
Dr. Gail Tomblin Murphy joins as one of the 14 experts on pan-Canadian national coalition
November 18, 2022
2
Min Read
Experts to advise and inform immediate and longer-term solutions to address significant health workforce challenges A pan-Canadian team of 14 experts brought together by The Honourable Jean-Yves Duclos, Minister of Health of Canada; The Honourable Carolyn Bennett, Minister of Mental...
page
Frequently Used and Approved RID Contract Templates
innovationhub.nshealth.ca/support-and-resources/contracts/frequently-used-and-approved-rid-contract-templates
Master Agreements To improve negotiation timelines and to ensure mutually agreeable terms and conditions between and amongst RID and external parties, master agreement templates are negotiated. These master agreements are in force for 2-3 years as negotiated. The parties to the agreement are the external third party and Nova Scotia...
News Article
Meet David Kerr, Corporate Residency MBA Student with the Nova Scotia Health Innovation Hub
April 22, 2022
3
Min Read
The Nova Scotia Health Innovation Hub is proud to welcome four Dalhousie University Corporate Residency MBA Students to our team this semester. Learn more about David Kerr, a Toronto native with a passion for medical technology and start up opportunities...
News Article
Clinical trials bring new hope and treatments to Nova Scotians
February 3, 2026
3
Min Read
Nova Scotia Health's ACCRU becomes first site in Canada to open the Novartis Adjuvant WIDER global clinical trial evaluating whether a medication called ribociclib can lower the risk of early-stage breast cancer returning.
